Trusted News Discovery Since 2008
{{/content}}
‘Doses approved by US regulators…’: Centre on vaccines, Remdesivir use | Covid
Video Credit: HT Digital Content
Published on April 13, 2021 - Duration: 06:23s
‘Doses approved by US regulators…’: Centre on vaccines, Remdesivir use | Covid
The Centre on Tuesday said doctors should ensure "rational and judicious" use of anti-viral drug Remdesivir, underlining it is to be given only to serious COVID-19 patients in hospitals and is not to be used in home settings.
NITI Aayog member (Health) Dr V K Paul said, "Remdesivir is to be used only in those who require hospitalisation and are on oxygen support.
That is the precondition.
There is no question of its use in the home setting and for mild cases, and it is not to be procured from chemist shops." "We appeal to physicians to ensure rational, correct and judicious use of Remdesivir in hospitalised patients," he said.
Watch the full video for more details.
You are here
💡 newsR Knowledge: Other News Mentions
NITI Aayog
Indian government think tank
NITI Aayog proposes classifying factory worker housing as a separate category to streamline taxes and boost manufacturing. This aims to address housing..
Credit: IndiaTimes - Published 5 days ago
Related videos from verified sources
Don't visit vaccination centre, haven't received vaccines: CM Kejriwal 01:32
Video credit: ANI - Published on April 30, 2021
Covid vaccination registration for all above 18 yrs opens today: How to register 03:27
Video credit: HT Digital Content - Published on April 28, 2021
Rajasthan needs 7 crore doses for 3rd phase of COVID vaccination drive 02:07
Video credit: ANI - Published on April 28, 2021